Qualigen Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QLGN and other ETFs, options, and stocks.

About QLGN

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. 

CEO
Kevin A. Richardson
CEOKevin A. Richardson
Employees
4
Employees4
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
2004
Founded2004
Employees
4
Employees4

QLGN Key Statistics

Market cap
2.81M
Market cap2.81M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
—
Dividend yield—
Average volume
5.46K
Average volume5.46K
High today
$3.97
High today$3.97
Low today
$3.77
Low today$3.77
Open price
$3.88
Open price$3.88
Volume
5.16K
Volume5.16K
52 Week high
$29.44
52 Week high$29.44
52 Week low
$2.85
52 Week low$2.85

People also own

Based on the portfolios of people who own QLGN. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
AMC Entertainment
Cenntro Inc.
Assertio
Castor Maritime
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.